PLACEBO CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF SCX-001 CREAM IN BURN PATIENTS WITH STANDARDIZED DEEP DERMAL INCISIONS...NEW COOPERATIVE AGREEMENT, SIGNED ON 9/6/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/6/2019, FAADC 9/10/2019
$3,483,036FY2019Defense Health AgencyDOD
The Governors Of The University Of Alberta